Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
13.70
+0.46 (3.47%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Zymeworks Revenue

Zymeworks had revenue of $19.24M in the quarter ending June 30, 2024, with 174.82% growth. This brings the company's revenue in the last twelve months to $62.71M, down -85.99% year-over-year. In the year 2023, Zymeworks had annual revenue of $76.01M, down -81.57%.

Revenue (ttm)
$62.71M
Revenue Growth
-85.99%
P/S Ratio
16.06
Revenue / Employee
$225,558
Employees
278
Market Cap
973.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202376.01M-336.47M-81.57%
Dec 31, 2022412.48M385.80M1,446.03%
Dec 31, 202126.68M-12.27M-31.50%
Dec 31, 202038.95M9.41M31.84%
Dec 31, 201929.54M-23.48M-44.28%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetIQ 1.13B
Phibro Animal Health 1.02B
Bioventus 536.89M
Castle Biosciences 287.59M
CeriBell 54.46M
Liquidia 14.84M
Revenue Rankings